ZimVie (ZIMV) Revenue & Revenue Breakdown
ZimVie Revenue Highlights
Latest Revenue (Y)
$457.43M
Latest Revenue (Q)
$103.22M
Main Segment (Y)
Segment Total
Main Geography (Y)
UNITED STATES
ZimVie Revenue by Period
ZimVie Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $457.43M | -49.95% |
| 2022-12-31 | $913.86M | -9.93% |
| 2021-12-31 | $1.01B | 11.20% |
| 2020-12-31 | $912.40M | -13.56% |
| 2019-12-31 | $1.06B | -3.97% |
| 2018-12-31 | $1.10B | - |
ZimVie generated $457.43M in revenue during NA 2023, up -49.95% compared to the previous quarter, and up 41.62% compared to the same period a year ago.
ZimVie Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $103.22M | -11.63% |
| 2024-06-30 | $116.81M | -1.17% |
| 2024-03-31 | $118.19M | 4.54% |
| 2023-12-31 | $113.07M | -44.27% |
| 2023-09-30 | $202.87M | -9.79% |
| 2023-06-30 | $224.90M | -0.24% |
| 2023-03-31 | $225.43M | -1.61% |
| 2022-12-31 | $229.12M | 6.78% |
| 2022-09-30 | $214.58M | -8.52% |
| 2022-06-30 | $234.56M | -0.44% |
| 2022-03-31 | $235.60M | -9.94% |
| 2021-12-31 | $261.60M | 9.17% |
| 2021-09-30 | $239.62M | -9.82% |
| 2021-06-30 | $265.73M | 7.26% |
| 2021-03-31 | $247.73M | -9.88% |
| 2020-12-31 | $274.90M | - |
ZimVie generated $103.22M in revenue during Q3 2024, up -11.63% compared to the previous quarter, and up 45.90% compared to the same period a year ago.
ZimVie Revenue Breakdown
ZimVie Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 |
|---|---|---|
| Spine | $449.81M | $540.30M |
| Segment Total | $909.49M | $1.01B |
| Dental | $459.68M | $468.50M |
ZimVie's latest annual revenue breakdown by segment (product or service), as of Dec 22: Segment Total (50.00%), Dental (25.27%), and Spine (24.73%).
Quarterly Revenue by Product
| Product/Service | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|---|---|
| Dental | $105.31M | $118.65M | $120.17M | $115.84M | $105.12M | $118.15M | $120.57M |
| Spine | $97.56M | $106.25M | $104.92M | $112.32M | $108.15M | $115.22M | $114.11M |
| Segment Total | $202.87M | $224.90M | $225.09M | $228.16M | $213.27M | $233.37M | $234.68M |
ZimVie's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Segment Total (50.00%), Dental (25.96%), and Spine (24.04%).
ZimVie Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 |
|---|---|---|
| Other Countries | $279.35M | - |
| UNITED STATES | $630.14M | $675.60M |
ZimVie's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (69.29%), and Other Countries (30.71%).
Quarterly Revenue by Country
| Country | Sep 24 | Jun 24 | Mar 24 |
|---|---|---|---|
| UNITED STATES | $65.35M | $69.32M | $67.75M |
| SPAIN | $9.09M | $12.82M | $15.35M |
| Other Countries | $28.78M | $34.67M | $35.10M |
ZimVie's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (63.31%), Other Countries (27.88%), and SPAIN (8.81%).
ZimVie Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SYK | Stryker | $20.50B | $5.49B |
| SNN | Smith & Nephew | $5.55B | $2.79B |
| STE | STERIS | $5.14B | $1.28B |
| CNMD | CONMED | $1.24B | $316.70M |
| ZIMV | ZimVie | $457.43M | $103.22M |
| AORT | Artivion | $354.00M | $98.02M |
| INGN | Inogen | $315.66M | $88.77M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $39.97M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| APYX | Apyx Medical | $52.35M | $12.15M |
| CVRX | CVRx | $39.30M | $13.37M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
ZIMV Revenue FAQ
What is ZimVie’s yearly revenue?
ZimVie's yearly revenue for 2023 was $457.43M, representing a decrease of -49.95% compared to 2022. The company's yearly revenue for 2022 was $913.86M, representing a decrease of -9.93% compared to 2021. ZIMV's yearly revenue for 2021 was $1.01B, representing an increase of 11.20% compared to 2020.
What is ZimVie’s quarterly revenue?
ZimVie's quarterly revenue for Q3 2024 was $103.22M, a -11.63% decrease from the previous quarter (Q2 2024), and a -49.12% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $116.81M, a -1.17% decrease from the previous quarter (Q1 2024), and a -48.06% decrease year-over-year (Q2 2023). ZIMV's quarterly revenue for Q1 2024 was $118.2M, a 4.54% increase from the previous quarter (Q4 2023), and a -47.57% decrease year-over-year (Q1 2023).
What is ZimVie’s revenue growth rate?
ZimVie's revenue growth rate for the last 3 years (2021-2023) was -54.91%, and for the last 5 years (2019-2023) was -56.66%.
What are ZimVie’s revenue streams?
ZimVie's revenue streams in c 22 are Spine, Segment Total, and Dental. Spine generated $449.81M in revenue, accounting 24.73% of the company's total revenue, down -16.75% year-over-year. Segment Total generated $909.49M in revenue, accounting 50.00% of the company's total revenue, down -9.84% year-over-year. Dental generated $459.68M in revenue, accounting 25.27% of the company's total revenue, down -1.88% year-over-year.
What is ZimVie’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of ZimVie was Segment Total. This segment made a revenue of $909.49M, representing 50.00% of the company's total revenue.